InsiderTrades.com logo

ALLO Insider Trading

Insider Ownership Percentage: 13.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $294,129.46

Allogene Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Allogene Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Allogene Therapeutics Share Price & Price History

Current Price: $1.44
Price Change: ▼ Price Decrease of -0.08 (-5.26%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for ALLO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Allogene Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/21/2025Geoffrey M. ParkerCFOSell36,744$1.26$46,297.441,276,796View SEC Filing Icon  
4/21/2025Annie YoshiyamaSVPSell9,601$1.41$13,537.41130,663View SEC Filing Icon  
3/14/2025Benjamin Machinas BeneskiSVPSell5,488$1.98$10,866.24218,507View SEC Filing Icon  
3/14/2025David D. ChangCEOSell46,668$1.96$91,469.285,276,569View SEC Filing Icon  
2/3/2025Earl Martin DouglasSVPSell6,404$1.71$10,950.84587,848View SEC Filing Icon  
2/3/2025Geoffrey M. ParkerCFOSell4,361$1.73$7,544.531,301,540View SEC Filing Icon  
2/3/2025Timothy L MooreInsiderSell14,746$1.71$25,215.66250,713View SEC Filing Icon  
1/21/2025Zachary RobertsEVPSell27,199$1.78$48,414.22488,054View SEC Filing Icon  
12/9/2024Deborah M MessemerDirectorSell9,136$2.18$19,916.48157,629View SEC Filing Icon  
12/5/2024Franz B. HumerDirectorSell9,221$2.16$19,917.36307,507View SEC Filing Icon  
5/30/2024Franz B. HumerDirectorSell11,200$2.34$26,208.00255,253View SEC Filing Icon  
5/16/2024Arie BelldegrunDirectorBuy1,724,137$2.90$4,999,997.301,724,137View SEC Filing Icon  
1/30/2024Geoffrey M. ParkerCFOBuy190$3.60$684.00819,590View SEC Filing Icon  
12/18/2023Deborah M MessemerDirectorSell18,640$2.70$50,328.0062,456View SEC Filing Icon  
8/7/2023Stephen MayoDirectorSell10,000$4.29$42,900.0025,328View SEC Filing Icon  
2/13/2023Veer BhavnagriGeneral CounselSell3,000$6.85$20,550.00577,677View SEC Filing Icon  
1/17/2023Veer BhavnagriGeneral CounselSell3,000$7.04$21,120.00580,677View SEC Filing Icon  
12/15/2022Veer BhavnagriGeneral CounselSell5,602$7.53$42,183.06583,677View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Allogene Therapeutics (NASDAQ:ALLO)

83.63% of Allogene Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALLO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Allogene Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2025Caitong International Asset Management Co. Ltd24,047$30K0.0%+5,267.6%0.011%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co39,730$50K0.0%+27.3%0.018%Search for SEC Filing on Google Icon
11/17/2025XTX Topco Ltd774,203$0.96M0.0%+2,687.7%0.345%Search for SEC Filing on Google Icon
11/17/2025Scientech Research LLC26,635$33K0.0%N/A0.012%Search for SEC Filing on Google Icon
11/17/2025Mercer Global Advisors Inc. ADV23,998$30K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC3,390,026$4.20M0.0%+125.6%1.508%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.164,780$0.20M0.0%-8.2%0.073%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE974,320$1.21M0.0%-1.3%0.434%Search for SEC Filing on Google Icon
11/14/2025Zacks Investment Management526,132$0.65M0.0%+2.7%0.234%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP3,383,644$4.20M0.0%+109.7%1.506%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC250,000$0.31M0.0%N/A0.111%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC268,044$0.33M0.0%+1,383.7%0.119%Search for SEC Filing on Google Icon
11/13/2025Lynx1 Capital Management LP546,119$0.68M0.1%-95.1%0.243%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG3,571,157$4.43M0.0%+75.1%1.589%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets894,314$1.11M0.0%+1.7%0.398%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.21,844$27K0.0%+11,159.8%0.010%Search for SEC Filing on Google Icon
11/13/2025Dynamic Technology Lab Private Ltd39,677$50K0.0%N/A0.018%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC598,997$0.74M0.0%-7.2%0.267%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP2,090,753$2.59M0.0%-23.6%0.930%Search for SEC Filing on Google Icon
11/12/2025R Squared Ltd61,373$76K0.0%+88.8%0.027%Search for SEC Filing on Google Icon
11/12/2025Primecap Management Co. CA7,079,308$8.78M0.0%+23.8%3.150%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC71,895$89K0.0%-27.1%0.032%Search for SEC Filing on Google Icon
11/10/2025TD Asset Management Inc414,074$0.51M0.0%-24.1%0.184%Search for SEC Filing on Google Icon
11/10/2025Patient Square Capital LP2,981,396$3.70M1.0%+13.1%1.327%Search for SEC Filing on Google Icon
11/7/2025Harold Davidson & Associates Inc.295,432$0.37M0.2%+118.5%0.133%Search for SEC Filing on Google Icon
11/7/2025Levin Capital Strategies L.P.52,500$65K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP182,879$0.23M0.0%-62.8%0.082%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.9,020,770$11.19M0.0%+9.2%4.066%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.908,725$1.13M0.0%-2.7%0.410%Search for SEC Filing on Google Icon
11/7/2025Aberdeen Group plc1,582,265$1.96M0.0%+82.4%0.713%Search for SEC Filing on Google Icon
11/5/2025Moloney Securities Asset Management LLC514,000$0.64M0.1%+92.1%0.232%Search for SEC Filing on Google Icon
11/5/2025Savant Capital LLC21,645$27K0.0%N/A0.010%Search for SEC Filing on Google Icon
11/3/2025Coastal Bridge Advisors LLC21,789$27K0.0%-90.1%0.010%Search for SEC Filing on Google Icon
11/3/2025AustralianSuper Pty Ltd382,141$0.47M0.0%N/A0.170%Search for SEC Filing on Google Icon
10/31/2025Vanguard Personalized Indexing Management LLC85,720$0.11M0.0%+19.6%0.039%Search for SEC Filing on Google Icon
10/29/2025Wealth Enhancement Advisory Services LLC52,092$70K0.0%+178.0%0.023%Search for SEC Filing on Google Icon
10/15/2025CWM LLC64,332$80K0.0%+665.3%0.029%Search for SEC Filing on Google Icon
10/15/2025Vontobel Holding Ltd.62,080$77K0.0%+82.6%0.028%Search for SEC Filing on Google Icon
10/14/2025Brighton Jones LLC25,168$31K0.0%+81.6%0.011%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC26,852$33K0.0%-36.9%0.012%Search for SEC Filing on Google Icon
8/15/2025CANADA LIFE ASSURANCE Co31,211$35K0.0%+142.0%0.014%Search for SEC Filing on Google Icon
8/15/2025Man Group plc274,684$0.31M0.0%+47.6%0.126%Search for SEC Filing on Google Icon
8/15/2025Engineers Gate Manager LP32,465$37K0.0%N/A0.015%Search for SEC Filing on Google Icon
8/15/2025Brevan Howard Capital Management LP81,843$92K0.0%-66.7%0.037%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE987,495$1.12M0.0%+4.1%0.451%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC412,630$0.47M0.0%-63.0%0.189%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.179,576$0.20M0.0%-37.2%0.082%Search for SEC Filing on Google Icon
8/14/2025Cerity Partners LLC400,267$0.45M0.0%+5.2%0.183%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.396,512$0.45M0.0%+39.0%0.181%Search for SEC Filing on Google Icon
8/13/2025Virtus Investment Advisers LLC67,166$76K0.0%-17.4%0.031%Search for SEC Filing on Google Icon
8/13/2025Quadrature Capital Ltd44,050$50K0.0%+29.6%0.020%Search for SEC Filing on Google Icon
8/12/2025Foresite Capital Management VI LLC2,875,357$3.25M1.8%-16.6%1.315%Search for SEC Filing on Google Icon
8/12/2025Rhumbline Advisers209,336$0.24M0.0%+14.0%0.096%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.934,023$1.06M0.0%-81.8%0.427%Search for SEC Filing on Google Icon
8/11/2025Primecap Management Co. CA5,719,140$6.46M0.0%+16.0%2.615%Search for SEC Filing on Google Icon
8/11/2025Patient Square Capital LP2,635,000$2.98M1.1%+11.3%1.205%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC98,671$0.11M0.0%-18.0%0.045%Search for SEC Filing on Google Icon
8/8/2025Creative Planning66,744$75K0.0%-31.2%0.031%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC3,794,827$4.29M0.0%+13.0%1.735%Search for SEC Filing on Google Icon
8/7/2025Mitsubishi UFJ Asset Management Co. Ltd.138,900$0.16M0.0%-47.4%0.064%Search for SEC Filing on Google Icon
8/7/2025Los Angeles Capital Management LLC35,970$41K0.0%N/A0.016%Search for SEC Filing on Google Icon
7/31/2025Moloney Securities Asset Management LLC267,500$0.30M0.0%-9.3%0.122%Search for SEC Filing on Google Icon
7/31/2025R Squared Ltd32,513$37K0.0%N/A0.015%Search for SEC Filing on Google Icon
7/25/2025Vanguard Personalized Indexing Management LLC71,688$81K0.0%+183.5%0.033%Search for SEC Filing on Google Icon
7/23/2025Vontobel Holding Ltd.34,000$38K0.0%-81.7%0.016%Search for SEC Filing on Google Icon
7/18/2025Bourgeon Capital Management LLC110,000$0.12M0.0%N/A0.050%Search for SEC Filing on Google Icon
7/11/2025Kingstone Capital Partners Texas LLC344,880$0.39M0.0%N/A0.158%Search for SEC Filing on Google Icon
6/4/2025Harold Davidson & Associates Inc.252,350$0.37M0.2%+8.5%0.115%Search for SEC Filing on Google Icon
5/19/2025Jane Street Group LLC1,116,681$1.63M0.0%+578.7%0.511%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.5,853,974$8.55M0.0%+177.9%2.676%Search for SEC Filing on Google Icon
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.286,033$0.42M0.0%-6.5%0.131%Search for SEC Filing on Google Icon
5/16/2025Curi RMB Capital LLC195,890$0.29M0.0%+31.0%0.090%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC58,223$85K0.0%N/A0.027%Search for SEC Filing on Google Icon
5/15/2025Frazier Life Sciences Management L.P.3,868,750$5.65M0.3%+34.9%1.769%Search for SEC Filing on Google Icon
5/15/2025DAFNA Capital Management LLC1,380,118$2.02M0.6%+11.3%0.631%Search for SEC Filing on Google Icon
5/14/2025MetLife Investment Management LLC79,823$0.12M0.0%+110.0%0.036%Search for SEC Filing on Google Icon
5/14/2025Partners Capital Investment Group LLP254,845$0.37M0.0%+173.3%0.117%Search for SEC Filing on Google Icon
5/14/2025Hsbc Holdings PLC81,435$0.12M0.0%+17.8%0.037%Search for SEC Filing on Google Icon
5/13/2025Brooklyn Investment Group30,731$45K0.0%N/A0.014%Search for SEC Filing on Google Icon
5/13/2025Aberdeen Group plc867,250$1.27M0.0%+138.0%0.397%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC215,366$0.31M0.0%N/A0.098%Search for SEC Filing on Google Icon
5/12/2025Invesco Ltd.285,207$0.42M0.0%+123.7%0.130%Search for SEC Filing on Google Icon
5/12/2025Mitsubishi UFJ Asset Management Co. Ltd.264,065$0.39M0.0%+4.1%0.121%Search for SEC Filing on Google Icon
5/9/2025Deutsche Bank AG99,544$0.15M0.0%+1,416.7%0.046%Search for SEC Filing on Google Icon
5/9/2025Charles Schwab Investment Management Inc.1,155,844$1.69M0.0%-2.8%0.528%Search for SEC Filing on Google Icon
5/9/2025Raiffeisen Bank International AG402,000$0.62M0.0%-6.5%0.184%Search for SEC Filing on Google Icon
5/8/2025XTX Topco Ltd20,746$30K0.0%-86.9%0.009%Search for SEC Filing on Google Icon
5/8/2025GSA Capital Partners LLP483,768$0.71M0.1%N/A0.221%Search for SEC Filing on Google Icon
5/6/2025Y Intercept Hong Kong Ltd43,940$64K0.0%N/A0.020%Search for SEC Filing on Google Icon
4/30/2025Cerity Partners LLC380,424$0.56M0.0%-1.8%0.175%Search for SEC Filing on Google Icon
4/30/2025Moloney Securities Asset Management LLC295,000$0.43M0.1%N/A0.136%Search for SEC Filing on Google Icon
4/28/2025Vontobel Holding Ltd.185,646$0.27M0.0%-5.0%0.085%Search for SEC Filing on Google Icon
4/17/2025Exchange Traded Concepts LLC68,858$0.10M0.0%+13.5%0.032%Search for SEC Filing on Google Icon
4/16/2025Wealth Enhancement Advisory Services LLC19,260$28K0.0%N/A0.009%Search for SEC Filing on Google Icon
4/8/2025Rhumbline Advisers183,708$0.27M0.0%-4.2%0.085%Search for SEC Filing on Google Icon
3/18/2025California State Teachers Retirement System135,554$0.29M0.0%+6.0%0.065%Search for SEC Filing on Google Icon
2/18/2025Navalign LLC59,865$0.13M0.0%-20.6%0.029%Search for SEC Filing on Google Icon
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC270,559$0.58M0.0%+18.2%0.129%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC20,345$43K0.0%-89.2%0.010%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP2,702,200$5.76M0.0%+12.1%1.289%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Allogene Therapeutics logo
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma; and is in Phase 1b clinical trial for the treatment of chronic lymphocytic leukemia. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase 1 clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; ALLO-316, an allogeneic CAR T cell product candidate that is in Phase 1 clinical trial for the treatment of advanced or metastatic RCC; ALLO-329 for the treatment of certain autoimmune diseases; DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors; and Claudin 18.2 for the treatment of gastric and pancreatic cancer. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California.
Read More on Allogene Therapeutics

Today's Range

Now: $1.44
Low: $1.41
High: $1.51

50 Day Range

MA: $1.28
Low: $1.05
High: $1.52

52 Week Range

Now: $1.44
Low: $0.86
High: $3.78

Volume

1,536,230 shs

Average Volume

2,359,507 shs

Market Capitalization

$323.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of Allogene Therapeutics?

Allogene Therapeutics' top insider shareholders include:
  1. David D Chang (CEO)
  2. Arie Belldegrun (Director)
  3. Geoffrey M Parker (CFO)
  4. Earl Martin Douglas (SVP)
  5. Zachary Roberts (EVP)
  6. Franz B Humer (Director)
  7. Timothy L Moore (Insider)
  8. Benjamin Machinas Beneski (SVP)
  9. Deborah M Messemer (Director)
  10. Annie Yoshiyama (SVP)
Learn More about top insider investors at Allogene Therapeutics.

Who are the major institutional investors of Allogene Therapeutics?

Allogene Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 4.07%
  2. Primecap Management Co. CA — 3.15%
  3. UBS Group AG — 1.59%
  4. Millennium Management LLC — 1.51%
  5. Two Sigma Investments LP — 1.51%
  6. Patient Square Capital LP — 1.33%
Learn More about top institutional investors of Allogene Therapeutics stock.

Which institutional investors are selling Allogene Therapeutics stock?

During the previous quarter, ALLO stock was sold by these institutional investors:
  1. Lynx1 Capital Management LP
  2. Dimensional Fund Advisors LP
  3. GSA Capital Partners LLP
  4. Coastal Bridge Advisors LLC
  5. TD Asset Management Inc
  6. Susquehanna International Group LLP
  7. Barclays PLC
  8. Intech Investment Management LLC
Within the previous year, company insiders that have sold Allogene Therapeutics company stock include:
  1. David D Chang (CEO)
  2. Arie Belldegrun (Director)
  3. Geoffrey M Parker (CFO)
  4. Earl Martin Douglas (SVP)
  5. Zachary Roberts (EVP)
  6. Franz B Humer (Director)
  7. Timothy L Moore (Insider)
  8. Benjamin Machinas Beneski (SVP)
  9. Deborah M Messemer (Director)
Learn More investors selling Allogene Therapeutics stock.

Which institutional investors are buying Allogene Therapeutics stock?

During the previous quarter, ALLO stock was acquired by institutional investors including:
  1. Millennium Management LLC
  2. Two Sigma Investments LP
  3. UBS Group AG
  4. Primecap Management Co. CA
  5. Vanguard Group Inc.
  6. XTX Topco Ltd
  7. Aberdeen Group plc
  8. AustralianSuper Pty Ltd
Within the previous year, these company insiders have bought Allogene Therapeutics stock:
  1. David D Chang (CEO)
  2. Arie Belldegrun (Director)
Learn More investors buying Allogene Therapeutics stock.